Asthma is an inflammatory disease that effect the lung, particularly the airways. So many death cases had been recorded in the last decade due to its complications. As the symptoms (wheezing, SOB, broncho spasm, etc..) frequency per a day increased, the mortality rate increases with the development of bad life style and bad triggers (smoke, dust, food, car full's, perfume, medication, food, etc..) there is a serious need to put a focus on the regulation of treatment and life style to these patient. Although asthma is multi factorial (genetic and environmental predisposing) with no statistically sufficient information in Iraq there is an increase the no hospital admittion daily and delay the responses to the treatment. Aim. to study the biochemical markers effect the cases of asthmas and to evaluate the abnormality in sleeping period, performing the job in these patients and the responses to the medication Methods. A study was made from 200 asthma patient, there were between seventeen and more years old, they admitted to the respiratory center in Najaf province at Sader medical city. It started from 10th of 2018 to 5th of 2019. A data was collected from the patients after direct contact with them or with their relatives. The SPSS version 20 and EXCIL programs were used for analysis of the information . Results. it revealed that the majority of the female patient aged how aged from 40 to 49 years old were depended on inhaled steroid during their first line treatment. These patients suffered from difficulty in having a normal life style or normal job requirement. Most of them suffered from shortness of breath (SOB), wheezing, tightness in the chest, they were suffered from difficulty in normal sleeping. Conclusion: asthma occurrence in Iraq is increased tremendously that required more interest with better improvement of life style to perform a good sleeping period and decrease the hospital admission frequency. Recommendation. a further life style rearrangement and more medical care should be occur to decrease the sudden attacks that it may effect on the life span of the patients.

1.
Asthma Fact sheet №307"
.
WHO. November 2013. Archived from the original on June 29
, 2011. Retrieved 3 March
2016
.
2.
Zyflo (Zileuton tablets)
"(PDF). United States Food and Drug Administration.
Cornerstone Therapeutics Inc
. June
2012
. p.
3.
Archived (PDF) from the original on 13 December 2014. Retrieved 12 December 2014.
4.
Yawn
B. P.
(September
2008
). "
Factors accounting for asthma variability: achieving optimal symptom control for individual patients
" (PDF).
Primary Care Respiratory Journal.
17
(
3
):
138
47
.
5.
Kumar
Vinay
,
Abbas
Abul
K.,
Fausto
Nelson
,
Aster
Jon
, eds. (
2010
).
Robbins and Cotran pathologic basis of disease
(
8th ed
.).
Saunders
. p.
688
.
6.
Martinez
F. D.
(
2007
). "
Genes, environments, development and asthma: a reappraisal
".
European Respiratory Journal.
29
(
1
):
179
84
7.
Miller
,
RL
,
Ho
SM
(March
2008
). "
Environmental epigenetics and asthma: current concepts and call for studies
".
American Journal of Respiratory and Critical Care Medicine.
177
(
6
):
567
73
.
8.
Tan
,
DJ
,
Walters
,
EH
,
Perret
,
JL
,
Lodge
,
CJ
,
Lowe
,
AJ
,
Matheson
,
MC
,
Dharmage
,
SC
(February
2015
). "
Age-of-asthma onset as a determinant of different asthma phenotypes in adults: a systematic review and meta-analysis of the literature
".
Expert Review of Respiratory Medicine.
9
(
1
):
109
23
.
9.
Lemanske
,
R. F.
,
Busse
,
W. W.
(February
2010
). "
Asthma: clinical expression and molecular mechanisms
".
J. Allergy Clin. Immunol.
125
(
2
Suppl 2):
S95
102
.
10.
Gibson
PG
,
McDonald
VM
,
Marks
GB
(September
2010
). "
Asthma in older adults
".
Lancet.
376
(
9743
):
803
13
.
11.
Kindermann
,
W.
(
2007
). "
Do inhaled beta(2)-agonists have an ergogenic potential in non-asthmatic competitive athletes?
".
Sports Medicine.
37
(
2
):
95
102
12.
Baur
,
X.
,
Aasen
,
T. B.
,
Burge
,
P. S.
,
Heederik
,
D.
,
Henneberger
,
P. K.
,
Maestrelli
,
P.
,
Schlünssen
,
V.
,
Vandenplas
,
O.
,
Wilken
,
D.
(Jun 1,
2012
).
ERS Task Force on the Management of Work-related, Asthma. "The management of work-related asthma guidelines: a broader perspective"
.
European Respiratory Review.
21
(
124
):
125
39
.
13.
Bassam
H.
,
Sonia
S.
,
Joan
B.
, et al
Asthma insights and reality in the United Arab Emirates
.
Ann Thorac Med
2010
;
5
:
217
21
.
14.
Adams
RJ
,
Fuhlbrigge
A.
,
Guilbert
T.
,
Lozano
P.
,
Martinez
F.
Inadequate use of asthma medication in the United States: results of the Asthma in America national population survey
.
J Allergy Clin Immunol
2002
;
110
:
58
64
.
15.
Arnaud
B.
,
Adam
D.
,
Philippe
G.
The Asthma Insights and Reality in the Maghreb (AIRMAG) study: perspectives and lessons
.
Respiratory Medicine
2009
;
103
: S2, S38,
S48
.
16.
National Heart Lung and Blood Institute
.
Global initiative for asthma. Global strategy for asthma management and prevention
.
NHLBI/WHO workshop report. Bethesda (MD): National Institutes of Health
;
1995
. Update
2005
. NIH publication #02-3659.
17.
Green
RJ
.
Asthma Control – Is there a problem?
.
SA Fam Pract
2006
;
48
(
4
):
32
36
.
18.
Khadadah
M.
,
Mahboub
B.
,
Al-Busaidi
NH
et al
Asthma Insights and Reality in the Gulf and the Near East
.
Int J Tuberc Lung Dis
2009
;
13
(
8
):
1015
22
.
19.
Klaus
F.
,
Mitsuru
A.
,
Christopher
K.
Worldwide severity and control of asthma in children and adults: The global Asthma Insights and Reality surveys
.
American Academy of Allergy, Asthma and Immunology
2004
;
114
:
40
47
.
20.
Laurent
L.
,
Eric
V.
,
Gilles
D.
, et al
Influence of patients’ characteristics and disease management on asthma control
.
J Allergy Clin Immunol
2006
;
117
:
1404
10
.
21.
Guidet
,
B.
,
Shah
,
S.V.
(
1989
).
Am. J. Physiolo.
,
257
(
26
),
440
Muslih
,
R.K.
,
AlNimer
,
M.S.
,
Al-
Zamely
, O.M. (
2002
).
The level of Malondialdehyde after activation with H2O2 and CuSO4 and inhibition by deferoxamine and molsidomine in the serum of patient with acute myocardial infarction
.
Nat. J. Chem.
,
5
,
139
148
.
This content is only available via PDF.
You do not currently have access to this content.